Yangzhou Su
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Papers in
-
- Genomics and Chromatin Dynamics 1
- Protein Degradation and Inhibitors 1
- Histone Deacetylase Inhibitors Research 1
- Advanced biosensing and bioanalysis techniques 1
- RNA Interference and Gene Delivery 1
- Circular RNAs in diseases 1
-
- Immunotherapy and Immune Responses 1
- Co-authors
- Cong Li (2 shared papers)Suye Zhong (2 shared papers)Yongguang Tao (2 shared papers)Zuping He (1 shared paper)Chao Chen (1 shared paper)Yiqun Jiang (1 shared paper)Junjun Yang (1 shared paper)Bang Liu (1 shared paper)
- Journals
- Clinical and Translational Medicine (1 paper)Cancer Immunology Immunotherapy (1 paper)Signal Transduction and Targeted Therapy (1 paper)Science Advances (1 paper)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Yangzhou Su
4 papers receiving 1.0k citations
Yangzhou Su's Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 460
- Molecular Biology 833
- Immunology 126
- Oncology 88
- Microbiology 20
Countries citing papers authored by Yangzhou Su
This map shows the geographic impact of Yangzhou Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangzhou Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangzhou Su more than expected).
Fields of papers citing papers by Yangzhou Su
This network shows the impact of papers produced by Yangzhou Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangzhou Su. The network helps show where Yangzhou Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangzhou Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Exosomes: key players in cancer and potential therapeutic strategy Hit paper breakdown → | 2020 | 933 |
| 2 | 2022 | 97 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 3 |
About Yangzhou Su
Yangzhou Su is a scholar working on Molecular Biology, Immunology, Cancer Research, Infectious Diseases and Organic Chemistry, having authored 4 papers that have together received 1.0k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (1 paper), MicroRNA in disease regulation (1 paper), Immunotherapy and Immune Responses (1 paper), Protein Degradation and Inhibitors (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Advanced biosensing and bioanalysis techniques (1 paper), RNA Interference and Gene Delivery (1 paper) and Circular RNAs in diseases (1 paper). The work is most often cited by research in Cancer Research (460 citations), Molecular Biology (833 citations), Immunology (126 citations), Oncology (88 citations) and Microbiology (20 citations). Yangzhou Su has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Cong Li, Suye Zhong, Yongguang Tao, Zuping He, Chao Chen, Yiqun Jiang, Junjun Yang, Bang Liu, Jie Dai and Tao Wu. Their work appears in journals such as Clinical and Translational Medicine, Cancer Immunology Immunotherapy, Signal Transduction and Targeted Therapy and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.